89 related articles for article (PubMed ID: 8999481)
1. [Pulmonary embolism disclosing activated protein C resistance].
Strecker A; Bernardi F; Wolschies E; Hendricx S; Jude B
Rev Mal Respir; 1996 Oct; 13(5):521-2. PubMed ID: 8999481
[TBL] [Abstract][Full Text] [Related]
2. Activated protein C resistance--a major risk factor for thrombosis.
Rosén SB; Sturk A
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
[TBL] [Abstract][Full Text] [Related]
3. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent thromboembolism disclosing protein C deficiency. Apropos of a case with familial investigation].
Jonot F; Pouchelon E; Cambus JP; Bierme R; Leophonte P
Rev Pneumol Clin; 1990; 46(5):221-4. PubMed ID: 2075365
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
Weitz IC; Israel VK; Liebman HA
Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
[TBL] [Abstract][Full Text] [Related]
6. Life threatening pulmonary embolus in a factor V Leiden carrier on oral contraceptives: a case report.
Saif MW; Volpe BT; Dailey M; Tsongalis GJ
Conn Med; 1997 Jun; 61(6):333-7. PubMed ID: 9238827
[TBL] [Abstract][Full Text] [Related]
7. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to Gln and Cys-331 to Arg, leading to impaired secretion of mutant protein C.
Sugahara Y; Miura O; Hirosawa S; Aoki N
Thromb Haemost; 1994 Dec; 72(6):814-8. PubMed ID: 7740447
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
Martinelli I; Cattaneo M; Panzeri D; Mannucci PM
Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
[TBL] [Abstract][Full Text] [Related]
10. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
Dahlbäck B
Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
12. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
[TBL] [Abstract][Full Text] [Related]
13. Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutation.
Ireland H; Bayston T; Thompson E; Adami A; Gonçalves C; Lane DA; Finazzi G; Barbui T
Thromb Haemost; 1995 Apr; 73(4):731-2. PubMed ID: 7495091
[No Abstract] [Full Text] [Related]
14. [A case of congenital protein C deficiency with pulmonary thromboembolism].
Takeda K; Kumagai H; Hayashi S; Tanio Y; Kawase I; Kishimoto T; Fujiwara M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):497-501. PubMed ID: 8084108
[TBL] [Abstract][Full Text] [Related]
15. Activated protein C resistance and lupus anticoagulant in pregnancy.
Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
[TBL] [Abstract][Full Text] [Related]
16. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
De Bel AV; Van der Cruyssen GA; Devreese KM
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
[TBL] [Abstract][Full Text] [Related]
17. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature.
Worrall BB; Moazami G; Odel JG; Behrens MM
J Neuroophthalmol; 1997 Sep; 17(3):162-5. PubMed ID: 9304527
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary thromboembolism in a female with resistance to activated protein C].
Ribeiro A; Correia A; Fernandes F; Barbosa AP; Basto L; Lima F; Rodrigues P
Rev Port Cardiol; 1999 Jun; 18(6):601-7. PubMed ID: 10422456
[TBL] [Abstract][Full Text] [Related]
19. Laboratory diagnosis of resistance to activated protein C (APC-resistance).
Bertina RM
Thromb Haemost; 1997 Jul; 78(1):478-82. PubMed ID: 9198200
[No Abstract] [Full Text] [Related]
20. [Paraneoplastic superior vena cava thrombosis disclosing an ovarian tumor].
Padovani M; Tillie-Leblond I; Vennin P; Demarcq G; Wallaert B
Rev Mal Respir; 1996 Dec; 13(6):598-600. PubMed ID: 9036506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
